Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Companies

    Online pharmacies may list abroad

    By Zheng Yiran | China Daily | Updated: 2018-10-22 10:26
    Share
    Share - WeChat
    A visitor reads a brochure at the Ping An Good Doctor's booth during the World Artificial Intelligence Conference in Shanghai on Sept 21. [Photo provided to China Daily]

    111 Inc's Nasdaq IPO, Ping An Health Cloud's float in Hong Kong likely to spark a trend

    111 Inc, China's largest online pharmacy and healthcare service provider that started trading its American Depositary Shares on the Nasdaq stock market in September, is expected to inspire other firms to list overseas or in Hong Kong, market insiders said.

    Many popular online pharmacies in China are subsidiaries of established listed pharmaceutical companies. For instance, 360Kad belongs to Taiantang Pharmaceutical Co Ltd, Ehaoyao is from the Jointown Pharmaceutical Group, and Kede is under Conba Group.

    Market insiders said online pharmacies began as startups, so are preparing to list in the near future to raise funds for their planned expansion and diversification, and to create an exit route for existing investors.

    On Sept 12, 111 Inc raised $100 million from 8.25 million ADS at $14 apiece, at the lower end of the $14-$16 range. However, the amount raised was lower than $148.8 million it targeted from the planned issuance of 9.3 million ADS.

    "Floating on Nasdaq is both a milestone and a starting point for 111 Inc, and our mission is much bigger than public listing on the stock market," said Yu Gang, co-founder and executive chairman of 111 Inc.

    Yu told media that the high standards and transparency of Nasdaq would push the company toward greatness.

    Many online pharmacies have already raised multiple rounds of financing; investors need to withdraw, and listing is inevitable, said Zhang Yibing, general manager of AKang Pharmacy, in an interview to Healthpoint, a network of healthcare and related services.

    After online drugstore Jianke raised $50 million in its A round, its CEO Xie Fangmin said: "The company is well-prepared to list in the United States. We estimate to start trading on the Nasdaq stock market in the coming two to three years, and the company will possibly list on other main boards (as well)."

    Zou Yuming, former executive director of JP Morgan, was appointed senior vice-president of Jianke, sparking speculation that the company may be preparing to list.

    Chen Qiaoshan, a medical analyst at Beijing-based market consultancy Analysys, said: "Online pharmacies have a clear profit model. Currently, the government has favorable policies for them, in that the nation allows prescription drugs to be sold online.

    "Being listed on the market is beneficial to these online companies' development, no matter they want to extend offline pharmacy or cooperate with physical hospitals."

    Wang Yanxiong, founder of 360Kad, told Healthpoint that companies are also inspired by Ping An Health Cloud Co Ltd, an online pharmacy that listed in Hong Kong in May. Its estimated market value reached tens of billion yuan.

    Online pharmacies and Ping An Health Cloud are seen as being under the same healthcare umbrella.

    After listing in Hong Kong, sales revenues of Ping An Health Cloud reached 1.12 billion yuan ($162 million) in the first half of this year, according to its financial report. The health business was its fastest-growing section, yielding 628 million yuan in sales, over half of the total.

    According to the prospectus of 111 Inc, the company's sales revenue last year was 960 million yuan, and that of the first half of this year reached 731 million yuan.

    However, the company is still reeling from losses. In 2017, the company's net loss narrowed by 31 percent to 249 million yuan, and that of the first six months of this year was 129 million yuan.

    In 2017, the business-to-customer or B2C section of 111 Inc was valued at 862 million yuan, while the business-to-business or B2B side was valued at 86.89 million yuan. Although running for only over a year, its B2B business is growing rapidly, with the sales revenue reaching 317 million yuan in the first half of this year.

    The proportion of its B2B business increased from 9 percent in 2017 to 43.3 percent in the first half of this year. By the end of 2017, its B2B business had covered 48,000 pharmacies, and the repurchase rate of its B2B pharmacies was up to 66.5 percent.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    潮喷大喷水系列无码久久精品| 亚洲国产精彩中文乱码AV| 美丽姑娘免费观看在线观看中文版 | 亚洲Av无码国产情品久久| 夜夜添无码试看一区二区三区| 中文字幕色婷婷在线视频| 久久久久久亚洲Av无码精品专口| 中文字幕av高清有码| AV无码人妻中文字幕| 中文字幕亚洲欧美日韩在线不卡| 97久久精品无码一区二区| 无码囯产精品一区二区免费 | 少妇中文字幕乱码亚洲影视| 国产精品无码a∨精品| 亚洲AV无码1区2区久久| 亚洲AV无码无限在线观看不卡| 亚洲欧美中文日韩在线v日本 | 亚洲中文久久精品无码ww16| 精品久久久久久无码人妻热 | 久久精品无码免费不卡| 人妻无码αv中文字幕久久琪琪布| 亚洲第一极品精品无码久久| 亚洲中文字幕无码久久2017| 人妻中文无码久热丝袜| 丰满日韩放荡少妇无码视频| 亚洲欧美在线一区中文字幕 | 亚洲国产人成中文幕一级二级| 7777久久亚洲中文字幕| 日韩精品一区二区三区中文| av中文字幕在线| 最近免费中文字幕mv电影| 最近更新中文字幕第一页| 中文字幕一区二区精品区| 中文字幕视频在线| 日本欧美亚洲中文| 最新国产AV无码专区亚洲| 亚洲精品无码久久久久| 久久精品国产亚洲AV无码偷窥| 国产成人精品无码播放| 亚洲Av无码乱码在线播放| 日韩精品人妻一区二区中文八零|